Economic Burden of Invasive Meningococcal Infection in Children in the Republic of Belarus

Autor: E. N. Sergienko, I. N. Kozhanova, O. N. Romanova, A. D. Solodov, P. A. Sсutova

Publikováno v: Эпидемиология и вакцинопрофилактика, Vol 22, Iss 6, Pp 99-107 (2024)

Relevance Invasive meningococcal infection (IMI) is a significant clinical problem and is associated with a high probability of severe complications and death. Vaccination programs against meningococcus can achieve significant clinical effectiveness

Externí odkaz: https://doaj.org/article/f6f9e1c08c73469080026417c90489a8

The cost of individual health care in Serbia according to the international classification of diseases in the period 2010–2015

Autor: Gajić-Stevanović Milena, Simonović Periša, Banković-Lazarević Dušica, Stevanović Ivan, Stanković Lidija

Publikováno v: Stomatološki glasnik Srbije, Vol 64, Iss 1, Pp 14-23 (2017)

Introduction There is growing interest in the world for estimating the cost for the treatment of a disease. This value can be used to determine to which extent a particular disease or group of diseases burden society in terms of the global crisis (Se

Externí odkaz: https://doaj.org/article/c639e4914c5f4a268a5aab840478c758

Cout direct hospitalier de l’osteomyelite aiguë chez l’enfant drepanocytaire au CHU Sylvanus Olympio de Lome : Direct hospital costs of acute osteomyelitis in children with sickle cell disease

Autor: Guedenon, KM, Fiawoo, M, Akolly, DAE, Dossou, FC, Takassi, O, Esso, B, Iossa, L, Agbeko, Y, Geraldo, A., Padaro, E, Djadou, KE, Atakouma, DY, Gbadoe, AD

Publikováno v: Journal de la Recherche Scientifique de l’Université de Lomé; Vol. 23 No. 3 (2021); 329-336

Objectif : Évaluer le coût global moyen de la prise en charge de l’Ostéomyélite Aigüe (OA) chez un enfant drépanocytaire.Méthode : Étude rétrospective sur la période du 1er janvier 2008 au 30 novembre 2019, portant sur 23 dossiers de pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::31a9ded16e9a1b6de3392783c52b6fb7
https://www.ajol.info/index.php/jrsul/article/view/222315

Impact of the 13-Valent Conjugated Pneumococcal Vaccine on the Direct Costs of Invasive Pneumococcal Disease Requiring Hospital Admission in Children Aged < 5 Years: A Prospective Study

Autor: Hernández S, Navas E, Aznar, I., Ciruela P, García-García JJ, Moraga-Llop F, Munoz-Almagro C, Codina G, Fernández de Sevilla-Estrach M, González-Peris S, Esteva-Afonso C, Planes AM, Izquierdo C, Johanna Martínez Osorio, Campins M, Uriona S, Salleras L, Serrano-Blanco A, Jané M, Domínguez A

Publikováno v: Vaccines
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu

The lack of invasive pneumococcal disease (IPD) cost studies may underestimate the effect of pneumococcal polysaccharide conjugated vaccines (PCV). The objective of this study was to estimate the direct costs of hospitalized IPD cases. A prospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::918f17035f5d5bc869d13113f4f172e0
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=17958

The Financial Implications of a Well-Hidden and Ignored Chronic Lyme Disease Pandemic

Autor: Marcus Davidsson

Publikováno v: Healthcare, Vol 6, Iss 1, p 16 (2018)
Healthcare
Healthcare; Volume 6; Issue 1; Pages: 16

1 million people are predicted to get infected with Lyme disease in the USA in 2018. Given the same incidence rate of Lyme disease in Europe as in the USA, then 2.4 million people will get infected with Lyme disease in Europe in 2018. In the USA by 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86c47885368a746bfd354d1a5d907e6f
http://www.mdpi.com/2227-9032/6/1/16